New Hydrazone Derivatives Based on Pyrazolopyridothiazine Core as Cytotoxic Agents to Colon Cancers: Design, Synthesis, Biological Evaluation, and Molecular Modeling
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400687 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Teresa Glomb und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556, Wroclaw, Poland. Hauptthemen laut MEDLINE: Hydrazones, Antineoplastic Agents, Drug Design, Colonic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Ministry of Health.
Abstract (Originalsprache)
In this research, a series of novel hydrazone derivatives based on pyrazolopyridothiazinylacetohydrazide were designed, synthesized, and evaluated for their in vitro cytotoxic potency on several human colon cancer cells (HTC116, HT‐29, and LoVo). After MTT and SRB assays four of the most active derivatives: hydrazide GH and hydrazones GH7 , GH8 , and GH11 , were chosen for further investigation. Hydrazone GH11 had the highest cytotoxic activity (IC 50 values of c.a. 0.5 μM). Additionally, the impact of novel derivatives on the oxidative stress level, apoptosis induction, and modulation of inflammation in colon cancer cells was examined. In all studies, the activity of the derivatives increased in order GH < GH7 < GH8 < GH11 . At the same time, most of the research was conducted on compounds combined with apple pectin (PC). The most interesting observation was that all the studied derivatives applied together with PC showed significantly higher activity than observed in the case of using PC, hydrazide, or hydrazones separately. Finally, computational chemistry methods (molecular modeling and Density Functional Theory – DFT) were used to complement the experimental studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556, Wroclaw, Poland.
- Department of Biophysics and Neuroscience, Faculty of Medicine, Wroclaw Medical University, Chałubińskiego 3 A, 50-368, Wroclaw, Poland.
- Department of Medical Physiology, Faculty of Health Sciences, Jagiellonian University Medical College, Michałowskiego Kraków, 12, 31-126, Krakow, Poland.
- Faculty of Chemistry, University of Wroclaw, F. Joliot-Curie 14, 50-383, Wroclaw, Poland.
- Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Pekarska 69, 79-010, Lviv, Ukraine.
ORCID-Profile: Teresa Glomb, Kamila Środa-Pomianek, Anna Palko-Łabuz, Olga Wesołowska, Agnieszka Wikiera, Kamil Wojtkowiak, Aneta Jezierska, Andrzej Kochel, Roman Lesyk, Piotr Świątek
Förderung
- Ministry of Health
Zitieren
APA
Glomb, T., Środa-Pomianek, K., Palko-Łabuz, A., Wesołowska, O., Wikiera, A., Wojtkowiak, K., Jezierska, A., Kochel, A., Lesyk, R., & Świątek, P. (2025). New Hydrazone Derivatives Based on Pyrazolopyridothiazine Core as Cytotoxic Agents to Colon Cancers: Design, Synthesis, Biological Evaluation, and Molecular Modeling. ChemMedChem. https://doi.org/10.1002/cmdc.202400687
Vancouver
Glomb T, Środa-Pomianek K, Palko-Łabuz A, Wesołowska O, Wikiera A, Wojtkowiak K, et al. New Hydrazone Derivatives Based on Pyrazolopyridothiazine Core as Cytotoxic Agents to Colon Cancers: Design, Synthesis, Biological Evaluation, and Molecular Modeling. ChemMedChem. 2025. doi:10.1002/cmdc.202400687
BibTeX
@article{Glomb2025,
author = {Glomb, Teresa and Środa-Pomianek, Kamila and Palko-Łabuz, Anna and Wesołowska, Olga and Wikiera, Agnieszka and Wojtkowiak, Kamil and Jezierska, Aneta and Kochel, Andrzej and Lesyk, Roman and Świątek, Piotr},
title = {New Hydrazone Derivatives Based on Pyrazolopyridothiazine Core as Cytotoxic Agents to Colon Cancers: Design, Synthesis, Biological Evaluation, and Molecular Modeling},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400687}
}
EUVIMED